echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > New synthetic interferon Alfacyte ™ treatment COVID-19: a major breakthrough has been made.

    New synthetic interferon Alfacyte ™ treatment COVID-19: a major breakthrough has been made.

    • Last Update: 2020-10-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Scottish biotech company ILC Therapeutics today announced that its unique synthetic interferon Alfacyte™ is 15-20 times more effective in preventing the spread of SARS-CoV-2, the virus that causes COVID-19, in cells than other available interferons such as alpha-2 and interferon beta-1a.
    independent study, led by viral disease expert Dr Catherine Adamson, showed that Alfacyte ™ has excellent anti-SARS-CoV-2 properties in in-body.
    Alphacyte ™ is a synthetic human interferon Alpha, invented by Professor William Stimson, founder and chief scientific officer of ILC Therapeutics.
    Professor William H. Stimson spent two decades studying all subtypes and their effectiveness as immunomodulants and antiviral agents, not only for COVID-19, but also for other coronavirus-based diseases, such as SARS or MERS.
    based on the most powerful interferon Alpha subsype, Professor William Stimson has built a new synthetic interferon Alphacyte ™.
    , chief executive of ILC Therapeutics, said: "This is a very positive development as the world prepares for the second wave of COVID-19 outbreaks."
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.